Cargando…

Comparative analysis of clinical and biological characteristics of COVID-19 patients: A retrospective cohort study

BACKGROUND: Coronavirus disease (COVID-19), caused by a betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly evolved into a pandemic since it was first reported in December 2019. thus, SARS-CoV-2 has become a major global public health issue. OBJECTIVE: The obje...

Descripción completa

Detalles Bibliográficos
Autores principales: Yahyaoui, Abir, Amrani, Abdessamad, Idrissi, Amjad, Belmahi, Sabrina, Nassiri, Oumaima, Mouhoub, Boutaina, Sebbar, Elhoucine, Hamaz, Siham, Choukri, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. on behalf of INDIACLEN. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691507/
https://www.ncbi.nlm.nih.gov/pubmed/36447933
http://dx.doi.org/10.1016/j.cegh.2022.101184
_version_ 1784837060980375552
author Yahyaoui, Abir
Amrani, Abdessamad
Idrissi, Amjad
Belmahi, Sabrina
Nassiri, Oumaima
Mouhoub, Boutaina
Sebbar, Elhoucine
Hamaz, Siham
Choukri, Mohammed
author_facet Yahyaoui, Abir
Amrani, Abdessamad
Idrissi, Amjad
Belmahi, Sabrina
Nassiri, Oumaima
Mouhoub, Boutaina
Sebbar, Elhoucine
Hamaz, Siham
Choukri, Mohammed
author_sort Yahyaoui, Abir
collection PubMed
description BACKGROUND: Coronavirus disease (COVID-19), caused by a betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly evolved into a pandemic since it was first reported in December 2019. thus, SARS-CoV-2 has become a major global public health issue. OBJECTIVE: The objective of this work is to compare demographics, comorbidities, clinical symptoms, biology and imaging findings between severe and non-severe COVID-19 patients and to identify clinical and biological risk factors and biomarkers for the development of severe COVID-19 as well as predictive thresholds for severity in order to best rationalize management and decrease the morbidity and mortality caused by this condition. PATIENTS AND METHODS: This is a single-center retrospective study, from June 25 to December 31, 2021, on 521 patients at the level of the unit COVID-19 of the central laboratory of the Mohammed VI University Hospital Center Oujda, then classified into two groups according to the severity of the disease. RESULTS: Out of a total of 521 patients, a severe group including 336 cases (64.5%) and a non-severe group with 185 cases (35.5%). Hypertension, diabetes and obesity were noted in the majority of patients. Severe COVID-19 cases had higher C-reactive protein, procalcitonin, D-dimer, ferritin, elevated white blood cell count, and lower lymphocyte count than non-severe cases with a significant difference between the two groups. The areas under the curve (AUC) for C-reactive protein, procalcitonin and D-dimer were 0.886, 0.708, and 0.736 respectively. The optimal thresholds predictive of severity were 105 mg/l for C-reactive protein, 0.13 ng/ml for procalcitonin, 7420/μl for white blood cell count, and 0.55 mg/l for D-dimer. CONCLUSION: Comparison of the proportion of clinical, biological and radiological data between severe and non-severe cases of COVID-19, as well as identification of biomarkers for the development of severe form in the present study, will allow optimal streamlining of management with rapid triage of patients.
format Online
Article
Text
id pubmed-9691507
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Authors. Published by Elsevier B.V. on behalf of INDIACLEN.
record_format MEDLINE/PubMed
spelling pubmed-96915072022-11-25 Comparative analysis of clinical and biological characteristics of COVID-19 patients: A retrospective cohort study Yahyaoui, Abir Amrani, Abdessamad Idrissi, Amjad Belmahi, Sabrina Nassiri, Oumaima Mouhoub, Boutaina Sebbar, Elhoucine Hamaz, Siham Choukri, Mohammed Clin Epidemiol Glob Health Article BACKGROUND: Coronavirus disease (COVID-19), caused by a betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly evolved into a pandemic since it was first reported in December 2019. thus, SARS-CoV-2 has become a major global public health issue. OBJECTIVE: The objective of this work is to compare demographics, comorbidities, clinical symptoms, biology and imaging findings between severe and non-severe COVID-19 patients and to identify clinical and biological risk factors and biomarkers for the development of severe COVID-19 as well as predictive thresholds for severity in order to best rationalize management and decrease the morbidity and mortality caused by this condition. PATIENTS AND METHODS: This is a single-center retrospective study, from June 25 to December 31, 2021, on 521 patients at the level of the unit COVID-19 of the central laboratory of the Mohammed VI University Hospital Center Oujda, then classified into two groups according to the severity of the disease. RESULTS: Out of a total of 521 patients, a severe group including 336 cases (64.5%) and a non-severe group with 185 cases (35.5%). Hypertension, diabetes and obesity were noted in the majority of patients. Severe COVID-19 cases had higher C-reactive protein, procalcitonin, D-dimer, ferritin, elevated white blood cell count, and lower lymphocyte count than non-severe cases with a significant difference between the two groups. The areas under the curve (AUC) for C-reactive protein, procalcitonin and D-dimer were 0.886, 0.708, and 0.736 respectively. The optimal thresholds predictive of severity were 105 mg/l for C-reactive protein, 0.13 ng/ml for procalcitonin, 7420/μl for white blood cell count, and 0.55 mg/l for D-dimer. CONCLUSION: Comparison of the proportion of clinical, biological and radiological data between severe and non-severe cases of COVID-19, as well as identification of biomarkers for the development of severe form in the present study, will allow optimal streamlining of management with rapid triage of patients. The Authors. Published by Elsevier B.V. on behalf of INDIACLEN. 2023 2022-11-25 /pmc/articles/PMC9691507/ /pubmed/36447933 http://dx.doi.org/10.1016/j.cegh.2022.101184 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Yahyaoui, Abir
Amrani, Abdessamad
Idrissi, Amjad
Belmahi, Sabrina
Nassiri, Oumaima
Mouhoub, Boutaina
Sebbar, Elhoucine
Hamaz, Siham
Choukri, Mohammed
Comparative analysis of clinical and biological characteristics of COVID-19 patients: A retrospective cohort study
title Comparative analysis of clinical and biological characteristics of COVID-19 patients: A retrospective cohort study
title_full Comparative analysis of clinical and biological characteristics of COVID-19 patients: A retrospective cohort study
title_fullStr Comparative analysis of clinical and biological characteristics of COVID-19 patients: A retrospective cohort study
title_full_unstemmed Comparative analysis of clinical and biological characteristics of COVID-19 patients: A retrospective cohort study
title_short Comparative analysis of clinical and biological characteristics of COVID-19 patients: A retrospective cohort study
title_sort comparative analysis of clinical and biological characteristics of covid-19 patients: a retrospective cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691507/
https://www.ncbi.nlm.nih.gov/pubmed/36447933
http://dx.doi.org/10.1016/j.cegh.2022.101184
work_keys_str_mv AT yahyaouiabir comparativeanalysisofclinicalandbiologicalcharacteristicsofcovid19patientsaretrospectivecohortstudy
AT amraniabdessamad comparativeanalysisofclinicalandbiologicalcharacteristicsofcovid19patientsaretrospectivecohortstudy
AT idrissiamjad comparativeanalysisofclinicalandbiologicalcharacteristicsofcovid19patientsaretrospectivecohortstudy
AT belmahisabrina comparativeanalysisofclinicalandbiologicalcharacteristicsofcovid19patientsaretrospectivecohortstudy
AT nassirioumaima comparativeanalysisofclinicalandbiologicalcharacteristicsofcovid19patientsaretrospectivecohortstudy
AT mouhoubboutaina comparativeanalysisofclinicalandbiologicalcharacteristicsofcovid19patientsaretrospectivecohortstudy
AT sebbarelhoucine comparativeanalysisofclinicalandbiologicalcharacteristicsofcovid19patientsaretrospectivecohortstudy
AT hamazsiham comparativeanalysisofclinicalandbiologicalcharacteristicsofcovid19patientsaretrospectivecohortstudy
AT choukrimohammed comparativeanalysisofclinicalandbiologicalcharacteristicsofcovid19patientsaretrospectivecohortstudy